Physician profile
John Mark Lacy
NPI 1538487939
$7,095.60
in general payments reported to CMS, 2019-2025
47 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $928 · 2020: $840 · 2021: $755 · 2022: $828 · 2023: $1,372 · 2024: $1,123 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,709 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,708.64 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,639.22 | 2019-2025 | General - Erectile Dysfunction, General - Female Sui, Ams 700 |
| Axonics, INC. | $587.55 | 2020-2023 | Axonics |
| Astellas Pharma US INC | $527.20 | 2019-2024 | Myrbetriq |
| Janssen Biotech, INC. | $500.46 | 2019-2025 | Erleada |
| Medtronic, INC. | $368.55 | 2021-2023 | Interstim |
| Endo Pharmaceuticals INC. | $337.33 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $245.34 | 2023-2025 | Orgovyx, Gemtesa |
| C. R. Bard, INC. & Subsidiaries | $221.22 | 2023-2025 | Bard Urinary Drainage Bag, Purewick Female External Catheter, Magic3 Go Intermittent Urinary Catheter |
| Endo USA, INC. | $199.46 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $177.18 | 2022-2025 | Barrigel, Urolift |
| Dornier Medtech America, INC | $166.09 | 2019-2020 | |
| Abbvie INC. | $152.15 | 2024-2025 | |
| Medtronic USA, INC. | $144.98 | 2019-2020 | |
| Neotract INC. | $143.57 | 2020 | |
| Antares Pharma, INC. | $137.11 | 2019-2023 | Tlando, Xyosted, Nocdurna |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lacy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.